Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

KOSDAQ/304360 stock hub

KOSDAQ/304360 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/304360is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

415.5B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/304360

In the news

Latest news · KOSDAQ/304360

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-40.3

P25 n/aP50 n/aP75 n/a

ROIC-15.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/304360 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

KRW

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Enterprise value	KRW 421.1B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 415.5B
Price	KRW 33,550
Price currency	KRW
Sic	2836
Symbol	kosdaq/304360
Website	https://www.sbiomedics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.95%
EV Earnings	-51.85x
EV/FCF	-49.06x
EV/Sales	25.45x
FCF yield	-2.07%
P/B ratio	24.84x
P/S ratio	25.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-50.42%
EBITDA Margin	-38.08%
Gross margin	45.61%
Gross Profit	KRW 7.5B
Gross Profit Growth	12.52%
Gross Profit Growth Q	-4.58%
Gross Profit Growth3 Y	7.29%
Gross Profit Growth5 Y	42.2%
Net Income	KRW -8.1B
Pretax Margin	-41.15%
Profit Margin	-49.08%
ROA	-12.15
Roa5y	-12.32
ROCE	-28.87
ROE	-40.3
Roe5y	-106.7
ROIC	-15.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	61.74%
Cagr3y	21.23%
Revenue Growth	20.49x
Revenue Growth Q	-9.35x
Revenue Growth3 Y	10.96x
Revenue Growth5 Y	25.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.39
Assets	KRW 41.2B
Cash	KRW 14.7B
Current Assets	KRW 19.8B
Current Liabilities	KRW 12.3B
Debt	KRW 12.2B
Debt Equity	KRW 0.73
Debt FCF	KRW -1.42
Equity	KRW 16.7B
Interest Coverage	-5.75
Liabilities	KRW 24.5B
Long Term Assets	KRW 21.4B
Long Term Liabilities	KRW 12.2B
Net Cash	KRW 2.5B
Net Cash By Market Cap	KRW 0.59
Net Cash Growth	-52.48%
Net Debt Equity	KRW -0.15
Tangible Book Value	KRW 8.3B
Tangible Book Value Per Share	KRW 683
WACC	12.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.61
Inventory Turnover	4.26
Net Working Capital	KRW -2.1B
Quick ratio	1.33
Working Capital	KRW 7.5B
Working Capital Turnover	KRW 1.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	61.69%
200-day SMA	28,242.5
3Y total return	78.17%
50-day SMA	32,898
50-day SMA vs 200-day SMA	50over200
All Time High	51,600
All Time High Change	-34.98%
All Time High Date	2024-06-25
All Time Low	6,950
All Time Low Change	382.73%
All Time Low Date	2023-11-13
ATR	2,132.2
Beta	1.52
Beta1y	1.29
Beta2y	1.33
Ch YTD	-11.59
High	34,250
High52	42,600
High52 Date	2026-01-08
High52ch	-21.24%
Low	33,250
Low52	17,930
Low52 Date	2025-09-01
Low52ch	87.12%
Ma50ch	1.98%
Price vs 200-day SMA	18.79%
RSI	52.2
RSI Monthly	56.36
RSI Weekly	53.33
Sharpe ratio	0.97x
Sortino ratio	1.69
Total Return	-3.22%
Tr YTD	-11.59
Tr1m	31.06%
Tr1w	-7.19%
Tr3m	9.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -8.3B
Operating margin	-50.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,125,433%
Net Borrowing	-1,479,570,130
Shares Insiders	21.64%
Shares Out	12,385,128
Shares Qo Q	1.24%
Shares Yo Y	3.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -9B
Average Volume	79,070.15x
Bv Per Share	709.8
CAPEX	KRW -4.6B
Ch1m	31.06
Ch1w	-7.19
Ch1y	61.69
Ch3m	9.46
Ch3y	78.17
Ch6m	51.13
Change	-1.61%
Change From Open	-1.18
Close	34,100
Days Gap	-0.44
Depreciation Amortization	2,042,907,210
Dollar Volume	1,737,453,850
Earnings Date	2026-04-06
EBIT	KRW -8.3B
EBITDA	KRW -6.3B
EPS	KRW -684
F Score	3
FCF	KRW -8.6B
FCF EV Yield	-2.04x
FCF Per Share	KRW -693
Financing CF	173,389,850
Fiscal Year End	December
Founded	2,005
Income Tax	KRW 250.5M
Investing CF	5,400,140,900
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Ma150	30,822
Ma150ch	8.85%
Ma20	32,867.5
Ma20ch	2.08%
Net CF	1,601,323,290
Open	33,950
Position In Range	30
Ppne	19,003,988,850
Price Date	2026-05-08
Ptbv Ratio	49.77
Relative Volume	0.65x
Revenue	16,547,626,700x
SBC By Revenue	2.67x
Share Based Comp	442,347,010
Tax By Revenue	1.51x
Tr6m	51.13%
Volume	51,787
Z Score	3.83

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/304360 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/304360 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/304360?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+21.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.2%

Negative means the company is buying back shares.

Technical

KOSDAQ/304360 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.2

Neutral momentum band

Price vs 200-day MA

+18.8%

50/200-day relationship not available

Beta (5Y)

1.52

More volatile than the market

Sharpe ratio

0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/304360

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/304360 stock rating?

kosdaq/304360 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/304360 analysis?

The full report lives at /stocks/kosdaq/304360/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/304360?

The latest report frames kosdaq/304360 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/304360 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.